Results 31 to 40 of about 5,163,498 (211)

Polo-Like Kinases: A Team in Control of the Division [PDF]

open access: yesCell Cycle, 2006
Polo, the founding member of the family of polo-like kinases (Plks) was identified in a Drosophila screen for mutants affecting spindle pole behavior.(1) Several mutants showed defects at their spindle poles and were hence named after the magnetic poles of the earth or geo-magnetic phenomena associated with them, like Polo and Aurora.
Barbara C M, van de Weerdt   +1 more
openaire   +2 more sources

The CINs of Polo-Like Kinase 1 in Cancer [PDF]

open access: yesCancers, 2020
Polo-like kinase 1 (PLK1) is overexpressed near ubiquitously across all cancer types and dysregulation of this enzyme is closely tied to increased chromosomal instability and tumor heterogeneity. PLK1 is a mitotic kinase with a critical role in maintaining chromosomal integrity through its function in processes ranging from the mitotic checkpoint ...
Chelsea E. Cunningham   +5 more
openaire   +2 more sources

On the regulation of centriole duplication in human cells : exploring the interactions of polo-like kinase 4 with the centrosomal proteins Cep192 and STIL [PDF]

open access: yes, 2015
Centrioles duplicate once in each cell cycle to give rise to two centrosomes that form the spindle poles during mitosis. Aberrant centriole duplication can result in the formation of supernumerary centrosomes, leading to incorrect spindle assembly and ...
Gabryjonczyk, Anna-Maria
core   +1 more source

Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms

open access: yesHaematologica, 2017
Nearly one-third of patients with acute myeloid leukemia have FMS-like tyrosine kinase 3 mutations and thus have poor survival prospects. Receptor tyrosine kinase anexelekto is critical for FMS-like tyrosine kinase 3 signaling and participates in FMS ...
Peter P. Ruvolo   +11 more
doaj   +1 more source

Divergent polo box domains underpin the unique kinetoplastid kinetochore [PDF]

open access: yesOpen Biology, 2016
Kinetochores are macromolecular machines that drive eukaryotic chromosome segregation by interacting with centromeric DNA and spindle microtubules. While most eukaryotes possess conventional kinetochore proteins, evolutionarily distant kinetoplastid ...
Olga O. Nerusheva, Bungo Akiyoshi
doaj   +1 more source

STIL binding to Polo-box 3 of PLK4 regulates centriole duplication [PDF]

open access: yes, 2015
Polo-like kinases (PLK) are eukaryotic regulators of cell cycle progression, mitosis and cytokinesis; PLK4 is a master regulator of centriole duplication.
Timm Maier   +15 more
core   +1 more source

Human Polo-like Kinase Inhibitors as Antiplasmodials

open access: yesACS Infectious Diseases, 2023
Protein kinases have proven to be a very productive class of therapeutic targets, and over 90 inhibitors are currently in clinical use primarily for the treatment of cancer. Repurposing these inhibitors as antimalarials could provide an accelerated path to drug development.
Monica J. Bohmer   +16 more
openaire   +4 more sources

Polo-like kinase-activating kinases [PDF]

open access: yesCell Cycle, 2012
The events of cell division are regulated by a complex interplay between kinases and phosphatases. Cyclin-dependent kinases (Cdks), polo-like kinases (Plks) and Aurora kinases play central roles in this process. Polo kinase (Plk1 in humans) regulates a wide range of events in mitosis and cytokinesis.
Vincent, Archambault, Mar, Carmena
openaire   +2 more sources

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells [PDF]

open access: yes, 2011
High attrition rates of novel anti-cancer drugs highlight the need for improved models to predict toxicity. Although polo-like kinase 1 (Plk1) inhibitors are attractive candidates for drug development, the role of Plk1 in primary cells remains widely ...
Kappel, Sven   +74 more
core   +1 more source

Targeting Polo-like Kinase in Cancer Therapy [PDF]

open access: yesClinical Cancer Research, 2010
Abstract Polo-like kinases (Plk) function in mitosis and maintaining DNA integrity. There are four family members, of which Plk1 represents a target for anticancer therapy. Plk1 is only expressed in dividing cells with peak expression during G2/M.
Yan, Degenhardt, Thomas, Lampkin
openaire   +2 more sources

Home - About - Disclaimer - Privacy